Notably, we detected the circulating protein levels of SERPING1 in human plasma from healthy people (n = 23) and NSCLC patients (n = 51), and found a lower expression in NSCLC patients, suggesting the low levels of SERPING1 were associated with NSCLC risk (Fig. 1G). Here, SERPING1 is linked to non-small cell lung carcinoma.